Cyclohexene nucleic acids (CeNA) form stable duplexes with RNA and induce RNase H activity

Area of Science:

• Oligonucleotide chemistry
• Molecular biology
• Biochemistry

Background:

• Nucleic acid modifications are crucial for developing therapeutic agents.
• Cyclohexene nucleic acids (CeNA) represent a novel class of modified nucleic acids.

Purpose of the Study:

• To synthesize CeNA using established phosphoramidite chemistry.
• To evaluate the impact of CeNA incorporation on DNA/RNA duplex stability.
• To assess the nuclease resistance and RNase H activity of CeNA-containing oligonucleotides.

Main Methods:

• Classical phosphoramidite chemistry for CeNA synthesis.
• Hybridization studies to determine duplex stability (e.g., melting temperature analysis).
• Incubation with human serum to assess nuclease resistance.
• Assays with E. coli RNase H to evaluate RNA cleavage activity.

Main Results:

• CeNA was successfully synthesized and incorporated into DNA chains.
• Incorporation of CeNA significantly increased the stability of DNA/RNA duplexes.
• CeNA demonstrated remarkable stability against degradation in serum.
• CeNA/RNA hybrids effectively activated E. coli RNase H, leading to specific RNA cleavage.

Conclusions:

• CeNA is a promising nucleic acid analog with enhanced duplex stability and serum resistance.
• The ability of CeNA/RNA hybrids to activate RNase H opens avenues for targeted RNA degradation therapies.